ATG3

PF3D7_0905700 (ATG3) is the E2-like conjugating enzyme of the Plasmodium ATG8 conjugation system, catalyzing the lipidation of PfAtg8 with phosphatidylethanolamine (PMID:24786226). ATG3 engages PfAtg8 through an Atg8-family interacting motif spanning residues 103–110, and the co-crystal structure of PfAtg8 bound to this ATG3 peptide, resolved to 2.2 Å, showed that binding depends on a unique Apicomplexan loop in PfAtg8 that is absent from human Atg8 homologues (PMID:22982544). Disrupting the PfAtg8–ATG3 protein-protein interaction — whether by small molecules targeting the interface or the A-loop — prevents PfAtg8 lipidation and inhibits parasite growth in both blood and liver stages, establishing this interaction as essential for survival (PMID:24786226, PMID:26748931). In P. berghei the ATG3 ortholog is cotranscribed with ATG7 and ATG8 across parasitic stages, and the PfAtg8–ATG3 interaction mechanism is divergent from yeast and mammalian systems (PMID:24342964). The conjugation system in which ATG3 acts appears dedicated to apicoplast biology rather than canonical autophagy in blood-stage parasites, since lipidated PfAtg8 localizes to the apicoplast and no autophagosome-like structures form in erythrocytic stages (PMID:22900071).

1. 2012 High

   Establishing how ATG3 recognizes PfAtg8 was needed to define the molecular basis of the parasite conjugation machinery; the structure revealed a species-specific interaction interface.

   Evidence Co-crystal structure (2.2 Å) of PfAtg8 with the ATG3(103–110) AIM peptide plus in vitro interaction assays in P. falciparum

   PMID:22982544

   Open questions at the time

   • Structure covers only the ATG3 AIM peptide, not full-length ATG3 or its catalytic architecture
   • Does not demonstrate the lipidation reaction itself
2. 2012 Medium

   The functional purpose of the ATG8 conjugation system in blood-stage parasites was unclear; localization of lipidated PfAtg8 to the apicoplast pointed toward a non-canonical, organelle-maintenance role rather than autophagy.

   Evidence Fluorescence and immunoelectron microscopy plus membrane-association biochemistry in P. falciparum; ATG3 implicated as a component of the conjugation system

   PMID:22900071

   Open questions at the time

   • ATG3 itself was not directly localized, only inferred as part of the system
   • Does not exclude autophagy roles in other life-cycle stages
3. 2013 Medium

   Whether the Plasmodium ATG3–ATG8 interaction mirrors yeast/mammalian machinery was open; cotranscription and failed heterologous complementation defined it as mechanistically divergent.

   Evidence Transcriptional co-expression analysis, cross-species complementation in atg8Δ yeast, and heterologous localization in starved mammalian cells for P. berghei (with P. falciparum)

   PMID:24342964

   Open questions at the time

   • Interaction mechanism characterized indirectly through complementation failure
   • Does not resolve the catalytic mechanism of ATG3
4. 2014 Medium

   It was unknown whether ATG3 is the enzyme driving PfAtg8 lipidation and whether blocking the interaction is sufficient to kill parasites; inhibitor studies assigned ATG3 the E2 role and validated it as a drug target.

   Evidence Surface plasmon resonance interaction inhibition, biochemical PfAtg8 lipidation assay, and blood- and liver-stage growth inhibition in P. falciparum

   PMID:24786226

   Open questions at the time

   • E2 assignment inferred from interaction inhibition rather than direct enzymatic reconstitution of ATG3 catalysis
   • Single lab
5. 2016 Medium

   To confirm the interaction is essential and druggable, the unique A-loop interface was targeted directly, yielding molecules that shift PfAtg8 lipidation and block growth.

   Evidence Virtual screening, SPR validation, PfAtg8 lipidation-state assay, and blood- and liver-stage growth inhibition in P. falciparum

   PMID:26748931

   Open questions at the time

   • Effects on lipidation state read out on PfAtg8, not on ATG3 activity directly
   • Molecular consequences for apicoplast maintenance not resolved

• The catalytic mechanism of ATG3 as an E2 enzyme, its full-length structure, and its direct role in apicoplast biology remain to be defined.
• No direct enzymatic reconstitution of ATG3-catalyzed PfAtg8 lipidation
• No full-length ATG3 structure
• ATG3's own localization and phenotype under genetic ablation uncharacterized in the corpus